Amended Statement of Ownership (sc 13g/a)
January 29 2016 - 9:34AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Trillium Therapeutics Inc.
(Name of Issuer)
Common Shares
(Title of Class of Securities)
89620X
(CUSIP Number)
December 31, 2015
(Date of Event which
Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
|
[_] |
Rule 13d-1(b) |
|
|
|
|
[X] |
Rule 13d-1(c) |
|
|
|
|
[_] |
Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a
reporting persons initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be filed for the purpose of Section 18 of the
Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities
of that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).
SCHEDULE 13G
1 |
Names of
Reporting Persons |
|
|
|
James H. Stebbins |
|
2 |
Check the appropriate box if a member of
a Group (see instructions) |
|
|
|
(a) [ ] |
|
|
(b) [ ] |
|
3 |
Sec Use
Only |
|
|
|
|
|
4 |
Citizenship or Place of Organization
|
|
|
|
United States |
|
Number
of Shares Beneficially Owned by Each
Reporting Person With:
|
5 |
Sole
Voting Power |
|
|
|
338,739 |
6 |
Shared Voting Power |
|
|
|
0 |
7 |
Sole
Dispositive Power |
|
|
|
338,739 |
8 |
Shared Dispositive Power |
|
|
|
0 |
9 |
Aggregate Amount Beneficially Owned by
Each Reporting Person |
|
|
|
James H. Stebbins -
338,739 |
10 |
Check box if the aggregate amount in row
(9) excludes certain shares (See Instructions) |
|
|
|
[ ] |
|
|
11 |
Percent of class represented by amount in
row (9) |
|
|
|
James H. Stebbins
4.3% |
12 |
Type of Reporting Person (See
Instructions) |
|
|
|
James H. Stebbins
IN (individual) |
Page 2 of 5
Item 1.
(a) |
Name of Issuer: Trillium Therapeutics
Inc. |
|
|
(b) |
Address of Issuers Principal Executive
Offices: 96 Skyway Avenue, Toronto, Ontario, Canada M9W
4Y9 |
Item 2.
(a) |
Name of Person Filing: James H. Stebbins |
|
|
(b) |
Address of Principal Business Office or, if None,
Residence: 222 East Wisconsin Avenue, Suite 303B, Lake Forest, IL
60045 |
|
|
(c) |
Citizenship: United States |
|
|
(d) |
Title and Class of Securities: Common
Stock |
|
|
(e) |
CUSIP No.: 89620X |
Item 3. |
If this statement is filed pursuant to §§
240.13d-1(b) or 240.13d-2(b) or (c), check whether the person
filing is a: |
|
(a) |
[_] |
Broker or dealer registered under Section 15 of the
Act; |
|
|
|
|
|
(b) |
[_] |
Bank as defined in Section 3(a)(6) of the Act; |
|
|
|
|
|
(c) |
[_] |
Insurance company as defined in Section 3(a)(19) of the
Act; |
|
|
|
|
|
(d) |
[_] |
Investment company registered under Section 8 of the
Investment Company Act of 1940; |
|
|
|
|
|
(e) |
[_] |
An investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E); |
|
|
|
|
|
(f) |
[_] |
An employee benefit plan or endowment fund in accordance
with Rule 13d-1(b)(1)(ii)(F); |
|
|
|
|
|
(g) |
[_] |
A parent holding company or control person in accordance
with Rule 13d-1(b)(1)(ii)(G); |
|
|
|
|
|
(h) |
[_] |
A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813); |
|
|
|
|
|
(i) |
[_] |
A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment Company Act of
1940; |
|
|
|
|
|
(j) |
[_] |
A non-U.S. institution in accordance with Rule
240.13d-1(b)(1)(ii)(J); |
|
|
|
|
|
(k) |
[_] |
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If
filing as a non-U.S. institution in accordance with Rule
240.13d-1(b)(1)(ii)(J), please specify the type of institution: |
|
|
|
____ |
(a) |
Amount Beneficially Owned: 338,739
shares |
Page 3 of 5
(b) |
Percent of Class: 4.3% |
|
|
|
(c) |
Number of shares as to which such person
has: |
|
|
|
|
(i) |
Sole power to vote or to direct the vote:
338,739 |
|
|
|
|
(ii) |
Shared power to vote or to direct the vote:
0 |
|
|
|
|
(iii) |
Sole power to dispose or to direct the disposition of:
338,739 |
|
|
|
|
(iv) |
Shared power to dispose or to direct the disposition
of: 0 |
Item 5. |
Ownership of Five Percent or Less of a
Class. |
If this statement is being filed to
report the fact that as of the date hereof the reporting person has ceased to be
the beneficial owner of more than five percent of the class of securities, check
the following [X].
Item 6. |
Ownership of more than Five Percent on
Behalf of Another Person. |
Item 7. |
Identification and classification of the
subsidiary which acquired the security being reported on by the
parent holding company or control person. |
Item 8. |
Identification and classification of members
of the group. |
Item 9. |
Notice of Dissolution of Group.
|
Page 4 of 5
SIGNATURE
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held
for the purpose of or with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose or
effect.
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: January 28, 2016
Signature: James H. Stebbins
Name: James H. Stebbins
The original statement shall be signed by each person on whose
behalf the statement is filed or his authorized representative. If the statement
is signed on behalf of a person by his authorized representative (other than an
executive officer or general partner of this filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.
Attention: Intentional misstatements or omissions of fact
constitute Federal criminal violations (See 18 U.S.C. 1001).
Page 5 of 5
Trillium Therapeutics (NASDAQ:TRIL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Trillium Therapeutics (NASDAQ:TRIL)
Historical Stock Chart
From Sep 2023 to Sep 2024